A group of three volunteers are set to receive the first shot of a 75mcg dose of the Nanocovax vaccine on January 18, the highest quantity of the vaccine which will be trialed on participants.

The human trial of Vietnam’s COVID-19 vaccine will begin on January 21-22, Health Minister Nguyen Thanh Long has stated.

Amidst the complicated developments of the COVID-19 pandemic in the world with over 85 million confirmed cases and 1.84 million deaths in 215 countries and territories, 

Vietnam will be supplied with 30 million doses of the Oxford-AstraZeneca COVID-19 vaccine within this year, a Vietnamese health official confirmed on Monday.

The Institute of Vaccines and Medical Biologicals (IVAC), based in central Khanh Hoa province, has proposed the Ministry of Health allow human trials of its COVID-19 vaccine to begin in January, two months ahead of schedule.

60-70 percent of people given Made-in-Vietnam Covid-19 vaccine have had slight fever and pain after receiving the trial shots.

Despite many difficulties, in order to protect people's health, the Government plans to both self produce and import Covid-19 vaccine in order to vaccinate every citizen.

The new mutant coronavirus strain found in the UK can spread more rapidly, raising concern about the effect of vaccines. Vietnam plans to implement gene sequencing of the virus sample.

Vietnam has raised concerns about the detection of a mutation of the SARS-CoV2 virus in the UK and is closely monitoring the situation in order to come up with appropriate prevention measures, according to Health Minister Nguyen Thanh Long.

A further 17 people out of the 60 volunteers participating in the first phase of human trials to develop Nanocovax, a locally-produced novel coronavirus (COVID-19) vaccine, received their vaccine shots on December 22 at the Military Medical Academy.

Vietnam has planned to test Nano Covax, a Covid-19 vaccine developed by HCMC-based Nanogen Pharmaceutical Biotechnology JSC, on 10,000-30,000 people in the third phase of the vaccine clinical trial,

The first human trial of COVID-19 vaccine Nanocovax began in Vietnam on December 17 with the first three volunteers, one man and two women aged 20-25, receiving injections at the Military Medical Academy.

Vietnam on December 17 started human trials of a COVID-19 vaccine, with vaccine injections taking place at the Hanoi-based Military Medical Academy.

Local COVID-19 vaccine Nanocovax is anticipated to be put into use by the middle of 2021 following the conclusion of the evaluation results of the ongoing human trials and the facilitation of administrative procedures,